(Q37216703)

19 August 2017

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer (English)

1 reference

19 August 2017

0 references

21

1 reference

19 August 2017

16

Barbara Jarzab

1 reference

19 August 2017

Federica Vianello

9

0 references

Agnieszka Czarniecka

Agnieszka Czarniecka

Garcilaso Riesco-Eizaguirre

15

0 references

Garcilaso Riesco-Eizaguirre

20

0 references

Caterina Mian

Caterina Mian

8

0 references

Rossella Elisei

Rossella Elisei

5

0 references

Alfred King-Yin Lam

Alfred K Lam

19

0 references

David Viola

4

David Viola

1 reference

19 August 2017

Roderick J Clifton-Bligh

28

Roderick Clifton-Bligh

1 reference

19 August 2017

25

Martha A Zeiger

1 reference

19 August 2017

3

Kathryn A Carson

1 reference

19 August 2017

29

David Sidransky

1 reference

19 August 2017

Christine J O'Neill

17

0 references

Sara I Pai

Sara I Pai

24

0 references

Eyal Robenshtok

11

Eyal Robenshtok

1 reference

19 August 2017

26

William H Westra

1 reference

19 August 2017

Mingzhao Xing

1

1 reference

19 August 2017

Ali S Alzahrani

2

1 reference

19 August 2017

Bela Bendlova

6

1 reference

19 August 2017

Linwah Yip

7

1 reference

19 August 2017

R Michael Tuttle

10

1 reference

19 August 2017

James A Fagin

12

1 reference

19 August 2017

Efisio Puxeddu

13

1 reference

19 August 2017

Laura Fugazzola

14

1 reference

19 August 2017

Mark S Sywak

18

1 reference

19 August 2017

Hirotaka Nakayama

22

1 reference

19 August 2017

Ralph P Tufano

23

1 reference

19 August 2017

Douglas P Clark

27

1 reference

19 August 2017

Paul W Ladenson

30

1 reference

19 August 2017

Vlasta Sykorova

31

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

The Journal of the American Medical Association

19 August 2017

1 reference

19 August 2017

309

1 reference

19 August 2017

14

1 reference

19 August 2017

1493-1501

1 reference

Molecular pathogenesis and mechanisms of thyroid cancer

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Thyroid cancer: burden of illness and management of disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Prognostic utility of BRAF mutation in papillary thyroid cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutation in thyroid cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Mutations of the BRAF gene in human cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary results.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutations in an Italian cohort of thyroid cancers.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutations in papillary carcinomas of the thyroid

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3791140

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

3 September 2018

1 reference

12 December 2020

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

12 December 2020

1 reference

12 December 2020

Confidence interval estimation of interaction

1 reference

12 December 2020

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

1 reference

12 December 2020

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2013.3190

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23571588

1 reference